Cavernous nerve injury using rodent animal models.

PubWeight™: 0.98‹?› | Rank: Top 15%

🔗 View Article (PMID 18774987)

Published in J Sex Med on August 01, 2008

Authors

Onder Canguven1, Arthur Burnett

Author Affiliations

1: James Buchanan Brady Urological Institute, The Johns Hopkins Hospital-Urology, Baltimore, MD 21287-2411, USA. ocanguv1@jhmi.edu

Articles citing this

Perioperative betamethasone treatment reduces signs of bladder dysfunction in a rat model for neurapraxia in female urogenital surgery. Eur Urol (2012) 1.37

Nerve growth factor modulation of the cavernous nerve response to injury. J Sex Med (2009) 1.06

Landmarks in erectile function recovery after radical prostatectomy. Nat Rev Urol (2015) 0.97

Increased expression of nestin in the major pelvic ganglion following cavernous nerve injury. Int J Impot Res (2011) 0.92

FK506 neuroprotection after cavernous nerve injury is mediated by thioredoxin and glutathione redox systems. J Sex Med (2011) 0.87

Neuronal nitric oxide signaling regulates erection recovery after cavernous nerve injury. J Urol (2011) 0.85

Valproic acid prevents penile fibrosis and erectile dysfunction in cavernous nerve-injured rats. J Sex Med (2014) 0.84

Topically applied NO-releasing nanoparticles can increase intracorporal pressure and elicit spontaneous erections in a rat model of radical prostatectomy. J Sex Med (2014) 0.83

Anti-inflammatory and anti-fibrotic effects of annexin1 on erectile function after cavernous nerve injury in rats. Int J Impot Res (2016) 0.75

GGF2 is neuroprotective in a rat model of cavernous nerve injury-induced erectile dysfunction. J Sex Med (2015) 0.75

Animal models of erectile dysfunction. Indian J Urol (2015) 0.75

Functional and molecular changes of the bladder in rats with crushing injury of nerve bundles from major pelvic ganglion to the bladder: role of RhoA/Rho kinase pathway. Int J Mol Sci (2013) 0.75